Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
In response to a report from the Government Accountability Office, the FDA says the biggest stumbling block to conducting ...
A New York aesthetician was arrested on Wednesday for allegedly buying counterfeit Botox from China and injecting it into ...
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
Rep. Nicole Malliotakis calls on Congress to put a stop to FDA-mandated animal testing for cosmetics
Representative Nicole Malliotakis (R-NY) talks about the Humane Cosmetics Act, a bill she cosponsored that would end required ...
After the FDA recently banned a food dye commonly used in many products nationwide, Cleveland Clinic helped shed some light as to why the product was banned.
The memo says staff should coordinate with presidential appointees before issuing official communications to public officials ...
Hosted on MSN10h
FDA Approves Treosulfan as Part of AML/MDS Conditioning RegimenThe FDA approved treosulfan (Grafapex) with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell ...
A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.
As nicotine packets like Zyn replace dipping tobacco, the spitter bottles of GWOT — gross, simple, everywhere — are not ...
The Trump administration has put a freeze on many federal health agency communications with the public through at least the ...
In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback